- Home
- YMAB vs EVM Comparison
YMAB vs EVM Comparison
Compare YMAB & EVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- EVM
- Stock Information
- Founded
- YMAB 2015
- EVM 2002
- Country
- YMAB United States
- EVM United States
- Employees
- YMAB N/A
- EVM N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- EVM Finance/Investors Services
- Sector
- YMAB Health Care
- EVM Finance
- Exchange
- YMAB Nasdaq
- EVM Nasdaq
- Market Cap
- YMAB 192.4M
- EVM 219.2M
- IPO Year
- YMAB 2018
- EVM N/A
- Fundamental
- Price
- YMAB $4.60
- EVM $8.79
- Analyst Decision
- YMAB Buy
- EVM
- Analyst Count
- YMAB 11
- EVM 0
- Target Price
- YMAB $17.55
- EVM N/A
- AVG Volume (30 Days)
- YMAB 226.0K
- EVM 55.8K
- Earning Date
- YMAB 05-13-2025
- EVM 01-01-0001
- Dividend Yield
- YMAB N/A
- EVM 4.01%
- EPS Growth
- YMAB N/A
- EVM N/A
- EPS
- YMAB N/A
- EVM 0.20
- Revenue
- YMAB $88,658,000.00
- EVM N/A
- Revenue This Year
- YMAB N/A
- EVM N/A
- Revenue Next Year
- YMAB $16.03
- EVM N/A
- P/E Ratio
- YMAB N/A
- EVM $47.61
- Revenue Growth
- YMAB 4.92
- EVM N/A
- 52 Week Low
- YMAB $3.55
- EVM $7.67
- 52 Week High
- YMAB $16.11
- EVM $9.59
- Technical
- Relative Strength Index (RSI)
- YMAB 56.43
- EVM 37.06
- Support Level
- YMAB $3.99
- EVM $8.81
- Resistance Level
- YMAB $5.00
- EVM $8.93
- Average True Range (ATR)
- YMAB 0.35
- EVM 0.09
- MACD
- YMAB 0.10
- EVM -0.01
- Stochastic Oscillator
- YMAB 70.47
- EVM 16.67
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income and alternative strategies to institutional investors, both in the United States and internationally.